New vaccine strategy could shield HIV patients from liver disease
NCT ID NCT00480792
First seen Apr 06, 2026 · Last updated May 06, 2026 · Updated 6 times
Summary
This study tested three different ways to vaccinate people with HIV against hepatitis B, a virus that can cause serious liver damage. The standard vaccine often doesn't work as well in HIV patients, so researchers compared a double dose and skin injections to the usual method. The goal was to see which approach helped more patients develop protective antibodies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hopital Cochin CIC de vaccinologie
Paris, 75014, France
Conditions
Explore the condition pages connected to this study.